Etoricoxib D3

Product Name Etoricoxib D3
Alternate Names Etoricoxib Stable Isotopes, Stable Isotopes of Etoricoxib
CAT No. CS-O-15694
CAS No. 850896-71-8
Category Stable Isotopes
Stock IN-Stock
Mol. Wt. 361.86 g/mol
Mol. For. C₁₈H₁₂D₃ClN₂O₂S
Hazardous This is not a Hazardous Compound
COA View Sample COA
MSDS View Sample MSDS
Parent API Etoricoxib
Smileys CC1=NC=C(C=C1)C2=C(C=C(C=N2)Cl)C3=CC=C(C=C3)S(=O)(=O)C
Canonical Smiles CC1=NC=C(C=C1)C2=C(C=C(C=N2)Cl)C3=CC=C(C=C3)S(=O)(=O)C
Inchl InChI=1S/C18H15ClN2O2S/c1-12-3-4-14(10-20-12)18-17(9-15(19)11-21-18)13-5-7-16(8-6-13)24(2,22)23/h3-11H,1-2H3/i2D3
IUPAC 5-chloro-2-(6-methylpyridin-3-yl)-3-[4-(trideuteriomethylsulfonyl)phenyl]pyridine
Controlled No
Shipping Free for purchase above 1000$
Delivery In-Stock, products will be dispatched within 24 hours via FedEx for USA, Europe, and other countries.
Return Returns/replacement accepted if you are not satisfied with the quality of the product, (please send us an email with the reason/issues which are facing, within 15 days, after receipt of the product).
Ordering Place your order online or by email
Etoricoxib D3 is a deuterated derivative of Etoricoxib, a non-steroidal anti-inflammatory drug (NSAID) that is commonly used for the treatment of arthritis and other inflammatory conditions. The deuterium labeling in Etoricoxib D3 is used for pharmacokinetic and metabolic studies, and it does not affect the therapeutic effects of the drug. Etoricoxib D3 works by inhibiting the cyclooxygenase-2 (COX-2) enzyme, which is responsible for the production of prostaglandins that cause inflammation, pain, and fever. By inhibiting COX-2, Etoricoxib D3 reduces inflammation and pain, and improves the mobility of joints affected by arthritis. Etoricoxib D3 is available in tablet form for oral administration, with a recommended dosage of 60 mg or 90 mg once daily. It is important to follow the dosage instructions provided by a healthcare professional, as the dosage may vary depending on the condition being treated and the patient's medical history. The chemical structure of Etoricoxib D3 is similar to that of other NSAIDs, with a sulfonamide group attached to a cyclooxygenase inhibitor. It has a molecular weight of 391.5 g/mol and a melting point of 234-238°C. Like other NSAIDs, Etoricoxib D3 may cause side effects such as stomach upset, dizziness, and headache. It may also increase the risk of cardiovascular events such as heart attack and stroke, especially in patients with a history of cardiovascular disease. Therefore, it is important to use Etoricoxib D3 only under the supervision of a healthcare professional, and to report any unusual symptoms or side effects to them immediately.

Related Compounds

Etoricoxib 13C6 | Etoricoxib 13CD3 | Etoricoxib D4 |

This page contains information about Etoricoxib D3. You can buy Etoricoxib D3 from Clearsynth at best competitive price with assured price guarantee. Clearsynth offers best quality Etoricoxib D3